Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects

Hanmi Pharmaceutical Company Limited24 enrolled

Overview

A randomized, open label, single-dose, 6-sequence, 3-period, crossover study to evaluate a pharmacokinetic drug interaction between eperisone hydrochloride and aceclofenac in healthy male subjects.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Acute Low Back Pain

Eligibility

Sex: MALEMin age: 20 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * BMI : 20.0 - 28.0 kg/m2 willingness to sign the written informed consent form(ICF) Exclusion Criteria: * Evidence of clinically relevant pathology within 30 days prior to drug administration History of relevant drug and/or food allergies

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.